Finance

Lists
002287:SHE
Tibet Cheezheng Tibetan Medicine Co Ltd
CN¥19,37
-0,92%
(-0,18) 1D
13 Okt., 15:04:48 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002287...
Open
CN¥19,36
High
CN¥19,55
Low
CN¥19,25
Mkt. cap
11,19 mjd
Avg. vol.
1,42 m
Volume
1,31 m
Dividend
3,30%
Quarterly dividend
CN¥0,16
Ex-dividend date
23 Sep. 2026
P/E ratio
16,54
52-wk high
CN¥27,33
52-wk low
CN¥18,33
EPS
CN¥1,17
Shares outstanding
572,12 m
No. of employees
3 k
Open
CN¥19,36
High
CN¥19,55
Low
CN¥19,25
Mkt. cap
11,19 mjd
Avg. vol.
1,42 m
Volume
1,31 m
Dividend
3,30%
Quarterly dividend
CN¥0,16
Ex-dividend date
23 Sep. 2026
P/E ratio
16,54
52-wk high
CN¥27,33
52-wk low
CN¥18,33
EPS
CN¥1,17
Shares outstanding
572,12 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Tibet Cheezheng Tibetan Medicine, or Tibet Qizheng Tibetan Medicine Co., Ltd is a prominent firm in the Tibetan medicine sector in China, primarily focused on the research, development, manufacture, and sales of Tibetan medicinal products. Wikipedia
About Tibet Cheezheng Tibetan Medicine Co Ltd
CEO-
Employees3,2 k
Founded1995
Headquarters-
SectorPharmaceutical industry
Websitecheezheng.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
347,89 m
893,07 m
405,25 m
572,72 m
Cost of goods sold
61,48 m
140,40 m
65,12 m
115,25 m
Cost of revenue
61,48 m
140,40 m
65,12 m
115,25 m
Research and development expenses
17,52 m
31,37 m
14,95 m
17,97 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
264,43 m
467,36 m
231,41 m
178,28 m
Operating expense
287,80 m
506,73 m
250,16 m
208,55 m
Total operating expenses
349,28 m
647,13 m
315,28 m
323,80 m
Operating income
-1,40 m
245,94 m
89,97 m
248,92 m
Other non operating income
269,69 k
-863,06 k
462,08 k
169,34 k
EBT including unusual items
69,67 m
267,60 m
109,04 m
305,43 m
EBT excluding unusual items
-8,28 m
245,93 m
90,15 m
249,46 m
Income tax expense
5,56 m
43,69 m
15,07 m
29,25 m
Effective tax rate
7,98%
16,33%
13,82%
9,58%
Other operating expenses
4,85 m
9,39 m
3,92 m
11,87 m
Net income
65,12 m
224,91 m
95,18 m
276,12 m
Net profit margin
18,72%
25,18%
23,49%
48,21%
Earnings per share
-
-
-
-
Interest and investment income
1,78 m
3,52 m
1,77 m
1,74 m
Interest expense
-9,89 m
-2,55 m
-2,05 m
-1,81 m
Net interest expenses
-8,11 m
978,68 k
-280,98 k
-63,34 k
Depreciation and amortization charges
-
-
-
-
EBITDA
25,60 m
279,82 m
123,85 m
283,96 m
Gain or loss from assets sale
909,31 k
-7,38 m
-
-248,14 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme